Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies

Can't see this email? View it online

	COVID-19
	The latest COVID-19 news from News Medical

	Futuristic AI-powered virtual lab designs potent SARS-CoV-2 nanobodies AI-human collaboration in a "Virtual Lab" successfully designs and experimentally validates nanobodies with enhanced binding to SARS-CoV-2 variants, offering a novel approach to interdisciplinary research.

	Pandemic linked to 16% rise in babies born with heart defects The proportion of babies born with a congenital heart abnormality increased by 16 per cent after the first year of the pandemic, according to research at City St George's, University of London and published today in Ultrasound in Obstetrics and Gynecology.

			HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase results suggest potential benefits.

			Long Covid could be costing the UK economy billions each year Working days lost to long Covid could be costing the economy billions of pounds every year as patients struggle to cope with symptoms and return to work, finds a new study led by UCL researchers.

			Study shows RSV’s severe impact on US adults, urging more testing and vaccination RSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the need for awareness and prevention efforts.

	Inequities in COVID-19 vaccination coverage for older adults highlighted in global study Researchers provide a global overview of COVID-19 vaccination programs among the elderly.

	Scientists fear what’s next for public health if RFK Jr. is allowed to ‘go wild’ Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty over how the president-elect will reconcile starkly different philosophies among the leaders of his team.

	Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not meeting statistical significance.

	FasL inhibitor speeds recovery and reduces mortality in severe COVID-19 patients A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality.

	As California taps pandemic stockpile for bird flu, officials keep close eye on spending California public health officials are dipping into state and federal stockpiles to equip up to 10,000 farmworkers with masks, gloves, goggles, and other safety gear as the state confirms at least 21 human cases of bird flu as of early November.

	Wellbeing in the USA shows significant disparities, driven by race, sex, age, and location A study reveals significant disparities in wellbeing across the U.S., influenced by race, ethnicity, and geography, affecting education, income, and lifespan.

	Next-generation metagenomic sequencing test quickly detects any kind of pathogen Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind of pathogen.

	Genomic surveillance could revolutionize the fight against antimicrobial resistance During the COVID-19 pandemic, genomic surveillance proved vital in helping understand the evolution and spread of the SARS-CoV-2 virus.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions